Insider Transactions in Q2 2021 at Matinas Bio Pharma Holdings, Inc. (MTNB)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Matthew Wikler Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,244
+3.57%
|
-
|
|
Jun 19
2021
|
Raphael J Mannino Chief Scientific Officer |
BUY
Conversion of derivative security
|
Direct |
20,000
+1.35%
|
-
|
|
Jun 19
2021
|
Raphael J Mannino Chief Scientific Officer |
BUY
Other acquisition or disposition
|
Direct |
8,000
+0.55%
|
-
|
|
Jun 19
2021
|
Herbert J Conrad Director |
BUY
Conversion of derivative security
|
Indirect |
200,000
+11.36%
|
-
|
|
Jun 19
2021
|
Herbert J Conrad Director |
BUY
Other acquisition or disposition
|
Indirect |
40,000
+2.86%
|
-
|
|
Jun 19
2021
|
Matthew Wikler Director |
BUY
Conversion of derivative security
|
Direct |
12,000
+4.31%
|
-
|
|
Jun 19
2021
|
Matthew Wikler Director |
BUY
Other acquisition or disposition
|
Direct |
2,400
+0.94%
|
-
|
|
Jun 19
2021
|
James S Scibetta Director |
BUY
Conversion of derivative security
|
Direct |
24,000
+3.56%
|
-
|
|
Jun 19
2021
|
James S Scibetta Director |
BUY
Other acquisition or disposition
|
Direct |
4,800
+0.76%
|
-
|
|
Jun 19
2021
|
Jerome D Jabbour President and CEO |
BUY
Conversion of derivative security
|
Direct |
30,000
+3.45%
|
-
|
|
Jun 19
2021
|
Jerome D Jabbour President and CEO |
BUY
Other acquisition or disposition
|
Direct |
6,000
+0.74%
|
-
|
|
Jun 19
2021
|
Eric J Ende Director |
BUY
Conversion of derivative security
|
Direct |
24,000
+14.28%
|
-
|
|
Jun 19
2021
|
Eric J Ende Director |
BUY
Other acquisition or disposition
|
Direct |
4,800
+3.84%
|
-
|
|
May 20
2021
|
Herbert J Conrad Director |
BUY
Bona fide gift
|
Indirect |
1,145,905
+46.45%
|
-
|
|
May 20
2021
|
Herbert J Conrad Director |
SELL
Bona fide gift
|
Indirect |
1,145,905
-100.0%
|
-
|